Cargando…

Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling

Purpose: Gastrointestinal stromal tumors (GISTs) are the most common malignant tumor of mesenchymal origin of the digestive tract. A yet more challenging resistance mechanism involves transition from oncogenic KIT to a new imatinib-insensitive oncogenic driver, heralded by loss of KIT expression. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ting, Ni, Nan, Yuan, Li, Xu, Liangliang, Bahri, Nacef, Sun, Boshu, Wu, Yuehong, Ou, Wen-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134732/ https://www.ncbi.nlm.nih.gov/pubmed/34025442 http://dx.doi.org/10.3389/fphar.2021.686874

Ejemplares similares

YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways
por: Ou, Wen-Bin, et al.
Publicado: (2021)

Tetramethylpyrazine Ameliorates Peritoneal Angiogenesis by Regulating VEGF/Hippo/YAP Signaling
por: Zhu, Xiaolin, et al.
Publicado: (2021)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
por: Huang, Mengyuan, et al.
Publicado: (2019)

Microtubule stabilization promotes the synthesis of type 2 collagen in nucleus pulposus cell by activating hippo-yap pathway
por: Zhang, Xin, et al.
Publicado: (2023)

Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
por: Zhao, Hui, et al.
Publicado: (2020)

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
por: Zuo, Wanyun, et al.
Publicado: (2021)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
por: Cho, Yong Suk, et al.
Publicado: (2021)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients
por: Yuan, Jia-qi, et al.
Publicado: (2020)

Chlamydia trachomatis induces the transcriptional activity of host YAP in a Hippo-independent fashion
por: Caven, Liam T., et al.
Publicado: (2023)

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib
por: Dalle Fratte, Chiara, et al.
Publicado: (2020)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells
por: Yoshida, Masahiro, et al.
Publicado: (2019)

β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis
por: Cai, Jing, et al.
Publicado: (2015)

Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
por: Xu, Zhi, et al.
Publicado: (2014)

C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
por: Seo, Ho Seok, et al.
Publicado: (2015)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
por: Mia, Masum M., et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
por: Cai, Yuanxia, et al.
Publicado: (2020)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1
por: Namgung, Hwan
Publicado: (2011)

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
por: Caenepeel, Sean, et al.
Publicado: (2010)

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
por: Katz, Steven C, et al.
Publicado: (2013)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
por: Suehara, Yoshiyuki, et al.
Publicado: (2018)

Morphological Correlates of KIT and PDGFRA Genotypes in Gastrointestinal Stromal Tumour
por: Priya, Valli, et al.
Publicado: (2020)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t4hiorpi380puj4acks0oha5bc